FDA approves Stryker's cementless Mako Total Knee with Triathlon Tritanium — 3 insights

Stryker's cementless Mako Total Knee with Triathlon Tritanium received FDA 510(k) market clearance.

Here's what you should know:

1. Stryker's Triathlon knee implant was improved with highly porous biologic fixation technology.

2. Stryker added a tibial baseplate and metal-backed patellar components to the implant. Stryker designed both with its modeling and analytics system.

3. The new implant expands upon existing robotic procedures by offering physicians a cementless solution.

Stryker Joint Replacement Division President Stuart Simpson said in a release, "With the rise in demand for cementless knee technology, we believe this new offering can have a positive impact on procedural efficiency and patient outcomes. We're excited to continue to lead in robotic technology and combine two of our most advanced and differentiated products to provide surgeons with the ability to transform orthopaedic surgery."

More articles on orthopedics:
Wright Medical settles metal-on-metal hip claims for $89.8M — 4 insights
Ibuprofen a better first-line option for pediatric postoperative orthopedic pain relief than morphine
Limited preoperative opioid use lowers pain scores post-TKA

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months